` Comparison: PCRX vs 3391 - Alpha Spread

PCRX
vs
3391

Over the past 12 months, PCRX has underperformed Tsuruha Holdings Inc, delivering a return of -15% compared to the Tsuruha Holdings Inc's +38% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
PCRX
3391
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

PCRX Intrinsic Value
0.289 CAD
Overvaluation 34%
Intrinsic Value
Price
Intrinsic Value
2 776.97 JPY
Undervaluation 12%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
PharmaCorp Rx Inc
XTSX:PCRX
0.435 CAD
Tsuruha Holdings Inc
TSE:3391
2 440 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
PCRX, 3391

PCRX
3391
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
PharmaCorp Rx Inc
Revenue
Tsuruha Holdings Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
PCRX, 3391

PCRX
3391
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
PharmaCorp Rx Inc
XTSX:PCRX
Tsuruha Holdings Inc
TSE:3391
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

PCRX
39.8%
Tsuruha Holdings Inc
30.2%

Operating Margin

PCRX
-1.4%
Tsuruha Holdings Inc
4.5%

Net Margin

PCRX
1.1%
Tsuruha Holdings Inc
3.1%

FCF Margin

PCRX
8.7%
Tsuruha Holdings Inc
6.8%

ROE

PCRX
0.6%
Tsuruha Holdings Inc
12.3%

ROA

PCRX
0.5%
Tsuruha Holdings Inc
5.9%

ROIC

PCRX
-0.7%
Tsuruha Holdings Inc
9.3%

ROCE

PCRX
-0.7%
Tsuruha Holdings Inc
13.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
PCRX, 3391

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PCRX, 3391

Loading
PCRX
3391
Difference
www.alphaspread.com

Performance By Year
PCRX, 3391

Loading
PCRX
3391
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare PCRX to other stocks
CLS
Clicks Group Ltd
C
Cheaper
vs PCRX
DCP
Dis-Chem Pharmacies Ltd
D
Cheaper
vs PCRX
WBA
Walgreens Boots Alliance Inc
Cheaper
vs PCRX
RADL3
Raia Drogasil SA
More expensive
vs PCRX
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett